The natural progression of Gambiense sleeping sickness: what is the evidence?
about
Estimating and mapping the population at risk of sleeping sicknessContemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: reviewEpidemiology of human African trypanosomiasisImplications of Heterogeneous Biting Exposure and Animal Hosts on Trypanosomiasis brucei gambiense Transmission and ControlTrypanosoma brucei gambiense Infections in Mice Lead to Tropism to the Reproductive Organs, and Horizontal and Vertical TransmissionMolecular epidemiology of African sleeping sickness.Murine Models for Trypanosoma brucei gambiense disease progression--from silent to chronic infections and early brain tropismIntroducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasisCardiac involvement with parasitic infections.Accuracy of five algorithms to diagnose gambiense human African trypanosomiasis.Importance of nonenteric protozoan infections in immunocompromised people.Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.Unravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNFα are associated with subsequent disease developmentStage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.Identifying transmission cycles at the human-animal interface: the role of animal reservoirs in maintaining gambiense human african trypanosomiasisProteomic selection of immunodiagnostic antigens for human African trypanosomiasis and generation of a prototype lateral flow immunodiagnostic deviceChallenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo.Trypanosoma brucei gambiense adaptation to different mammalian sera is associated with VSG expression site plasticity.Incorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in UgandaHuman African trypanosomiasis presenting at least 29 years after infection--what can this teach us about the pathogenesis and control of this neglected tropical disease?Updated estimate of the duration of the meningo-encephalitic stage in gambiense human African trypanosomiasis.Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections.Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challengesControlling sleeping sickness - a review.Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis.A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence.Development of novel drugs for human African trypanosomiasis.Proteomics: a new way to improve human African trypanosomiasis diagnosis?Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea.Latent Trypanosoma brucei gambiense foci in Uganda: a silent epidemic in children and adults?Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d'Ivoire.
P2860
Q21092278-98F1636E-4209-446D-A9A7-FBF84C568C81Q26825682-E4AB6654-C40E-4C5C-9ADF-6523ED985207Q27026504-40B40C6B-4379-421F-9785-C02F58758182Q27317424-89FE1024-E1D3-41B7-BCA4-9936D7B6EDD6Q28552110-411D1C04-A676-4CBC-B923-5331125A2B9FQ33347336-97E563E8-6141-45F6-8045-6AA0CE4680CEQ33498933-93B06367-754B-45BF-8FF9-03744E309D26Q33751576-4C0D3B03-07AF-4A70-AB67-0C5C6690735DQ33825602-1431B740-CEC4-4B28-85C1-3EF24FCCD7DDQ33959416-A76855B2-B9AE-4E77-A715-5E7DA5C06C98Q34189873-28251D0B-2271-4A0E-8ACF-E657630E370DQ34312428-36B9B2F1-3501-440E-AE72-D054D2E890C1Q34466454-23422FA8-8C04-4737-B4AD-21E172F4929FQ34474577-1388ED5F-57E3-410E-A225-3B302354414EQ34557971-A4AE192E-7D47-4E9D-8696-483E66F2CC5EQ34613645-ED3B2DE3-B80C-4046-B639-36D31A40917EQ35047661-B8A9367A-9BAE-4934-9C26-F60487D24942Q35078531-85201156-9093-4F30-B0A0-27F7E6E4292FQ35097828-4456C998-0C9E-4AD9-9EA5-CFADAFDE2E73Q35529820-40663E26-D0A5-4980-9B9C-2FA42D8CC2C4Q35682276-B0611A87-FEE5-47AF-835A-87D1980EEEDBQ36189949-3CE3EE53-2F7A-45FE-A376-5671C5347234Q37288857-F1EA74B0-7C9E-4605-9A22-A0207A763359Q37582546-0F207404-A316-4A31-83F0-F54746D1C692Q37609404-C69E4338-426C-4AE8-A80A-98880A2A3AD9Q37776021-C32652DD-D429-472E-86DA-24F11BEAF1BCQ37894699-2EFF11A3-5D39-4110-80B8-63EE8FC5D8DEQ38115332-3ED086D3-2698-4755-AED5-530D47C3E268Q38615202-6EDB80B1-38AF-4655-8302-794EAB7B274CQ38870242-27D1CC26-AC50-4D20-B9A1-3C099F97458AQ43923961-83C27AA7-315C-433D-829E-D863D1255682
P2860
The natural progression of Gambiense sleeping sickness: what is the evidence?
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The natural progression of Gambiense sleeping sickness: what is the evidence?
@ast
The natural progression of Gambiense sleeping sickness: what is the evidence?
@en
type
label
The natural progression of Gambiense sleeping sickness: what is the evidence?
@ast
The natural progression of Gambiense sleeping sickness: what is the evidence?
@en
prefLabel
The natural progression of Gambiense sleeping sickness: what is the evidence?
@ast
The natural progression of Gambiense sleeping sickness: what is the evidence?
@en
P2860
P1476
The natural progression of Gambiense sleeping sickness: what is the evidence?
@en
P2093
Daniel Chandramohan
Francesco Checchi
P2860
P356
10.1371/JOURNAL.PNTD.0000303
P407
P5008
P577
2008-12-23T00:00:00Z